Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-05-14
Original SEC Filing: Click here

---

Webplus: SVA/20150514/6-K/2_EX-99.1/000.htm SEC Original: v410724_ex99-1.htm
Sinovac Receives Site Inspection Notification for EV71 Vaccine Production Facilities BEIJING, May 14, 2014 — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company received site inspection notification for the commercial production facilities of its EV71 vaccine candidate from the China Food and Drug Administration (CFDA). This notification represents a significant step

---

---

Webplus: SVA/20150514/6-K/1/000.htm SEC Original: v410724_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-05-14CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085